Drug Study - Epinephrine

Posted by: Admin

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the much awaited November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!




by: JJ, RN

Action:

Naturally occurring catecholamine obtained from animal adrenal glands; also prepared synthetically. Acts directly on both alpha and beta receptors; the most potent activator of alpha receptors. Strengthens myocardial contraction; increases systolic but may decrease diastolic blood pressure; increases cardiac rate and cardiac output.

Classifications:

AUTONOMIC NERVOUS SYSTEM AGENT; ALPHA- AND BETA-ADRENERGIC AGONIST; BRONCHODILATOR

Indication:

Temporary relief of bronchospasm, acute asthmatic attack, mucosal congestion, hypersensitivity and anaphylactic reactions, syncope due to heart block or carotid sinus hypersensitivity, and to restore cardiac rhythm in cardiac arrest. Ophthalmic preparation is used in management of simple (open-angle) glaucoma, generally as an adjunct to topical miotics and oral carbonic anhydrase inhibitors; also used as ophthalmic decongestant. Relaxes myometrium and inhibits uterine contractions; prolongs action and delays systemic absorption of local and intraspinal anesthetics. Used topically to control superficial bleeding.

DOWNLOAD


Print This Post Print This Post
Email This Post Email This Post



_____________________________________________________________________________________________

  • Drug Study - Dopamine Hydrochloride by: ishi21, RN Dopastat, Intropin, Revimine Action: Naturally occurring neurotransmitter and immediate precursor of norepinephrine. Major cardiovascular effects produced by direct action on alpha- and beta-adrenergic receptors and on specific dopaminergic receptors in mesenteric and renal vascular beds. Classifications: AUTONOMIC NERVOUS SYSTEM AGENT; ALPHA- AND BETA-ADRENERGIC AGONIST (SYMPATHOMIMETIC) Indication: To correct hemodynamic imbalance in shock syndrome due to MI (cardiogenic shock),
  • Drug Study - Albuterol Salbutamol, Ventolin, Ventolin Rotocaps, Volmax Action: Synthetic sympathomimetic amine and moderately selective beta2-adrenergic agonist with comparatively long action. Acts more prominently on beta2 receptors (particularly smooth muscles of bronchi, uterus, and vascular supply to skeletal muscles) than on beta1 (heart) receptors. Minimal or no effect on alpha-adrenergic receptors. Inhibits histamine release by mast cells. Classifications: autonomic nervous system agent;
  • Drug Study - Clonidine Hydrochloride Catapres, Catapres-TTS, Dixaril , Duraclon Action: Centrally acting antiadrenergic derivative. Stimulates alpha2-adrenergic receptors in CNS to inhibit sympathetic vasomotor centers. Central actions reduce plasma concentrations of norepinephrine. It decreases systolic and diastolic BP and heart rate. Orthostatic effects tend to be mild and occur infrequently. Also inhibits renin release from kidneys.. Classifications: cardiovascular agent; central-acting antihypertensive; analgesic Indication: Step 2 drug
  • Drug Study - Gentamicin Sulfate Garamycin, Garamycin Ophthalmic, Genoptic Classifications: antiinfective; aminoglycoside antibiotic Action: Broad-spectrum aminoglycoside antibiotic derived from Micromonospora purpurea. Action is usually bacteriocidal. Indication: Parenteral use restricted to treatment of serious infections of GI, respiratory, and urinary tracts, CNS, bone, skin, and soft tissue (including burns) when other less toxic antimicrobial agents are ineffective or are contraindicated. Has been used in combination with
  • Drug Study - ATROPINE SULFATE Acts by selectively blocking all muscarinic responses to acetylcholine (ACh), whether excitatory or inhibitory. Selective depression of CNS relieves rigidity and tremor of Parkinson’s syndrome. Antisecretory action (vagolytic effect) suppresses sweating, lacrimation, salivation, and secretions from nose, mouth, pharynx, and bronchi. Blocks vagal impulses to heart with resulting decrease in AV conduction time, increase in

This entry was posted on Monday, June 9th, 2008 and is filed under Drug Study, Nursing News & Blog. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Subscribe by E-Mail or RSS

 
Get your copy now ! Use RSS. How? Click here.

Recent Forum Posts

Translator

Sponsors

Entrecard

Add Me

nursingcrib@yahoo.com